Abstract
Purpose
Well planned re-surgery is critical for recurrent/persistent thyroid cancer (TC). We aimed to investigate the clinical outcome of radioguided-occult lesion localization (ROLL) guided surgery in patients with recurrent/persistent TC.
Methods
This study includes 29 patients [F/M: 22/7, median age 43 ± 12 years (18–58)] with a diagnosis of TC (22 papillary, 2 follicular and 5 medullary). Before surgery, all patients underwent ultrasonography (USG) guided mapping and intra-lesional radioactivity injection. Surgery was performed based on the excision of radioactivity injected lesions by a gamma probe and non-injected tumor foci via USG-neck map. Researchers determined surgical success by post-operative tumor markers and neck-USG.
Results
Among 29 patients, 60 metastatic lesions were identified by USG [median size 10 ± 6.3 mm (range 5–30)]. Neck-USG performed after surgery provided no evidence of disease (NED) in %97 (28/29) of TC patients. In the follow-up, stimulated thyroglobulin (Tg) levels were less than 1 ng/ml in 79%(19/24) of DTC patients and suppressed Tg < 0.2 ng/ml was noted in 92% (22/24).In patients with DTC with an incomplete structural response, we dramatically changed the American Thyroid Association (ATA) response category and achieved an excellent response in 92% (22/24) of patients. Among patients with MTC, 5/5 patients had normal USG and calcitonin levels were reduced by 60–80% in 4/5 and > 80% in1/5 patients.
Conclusions
In this study we have shown that, ROLL-guided surgery yielded NED rate of %97 (28/29) and increased excellent response rates according to ATA guidelines. Further studies with larger patient groups and longer follow-up should be performed to confirm the efficacy of this surgery.
Similar content being viewed by others
References
American Thyroid Association Guidelines Taskforce on Thyroid N, Differentiated Thyroid C, Cooper DS, Doherty GM, Haugen BR, Kloos RT et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19(11):1167–1214
Mazzaferri EL, Kloos RT (2001) Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 86(4):1447–1463
Landis SH, Murray T, Bolden S, Wingo PA (1998) Cancer statistics, 1998. CA Cancer J Clin 48(1):6–29
Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97(5):418–428
Shen WT, Ogawa L, Ruan D, Suh I, Kebebew E, Duh QY et al (2010) Central neck lymph node dissection for papillary thyroid cancer: comparison of complication and recurrence rates in 295 initial dissections and reoperations. Arch Surg 145(3):272–275
Pai SI, Tufano RP (2010) Reoperation for recurrent/persistent well-differentiated thyroid cancer. Otolaryngol Clin North Am 43(2):353–363
Onkendi EO, McKenzie TJ, Richards ML, Farley DR, Thompson GB, Kasperbauer JL et al (2014) Reoperative experience with papillary thyroid cancer. World J Surg 38(3):645–652
Shaha AR, Jaffe BM (1998) Parathyroid preservation during thyroid surgery. Am J Otolaryngol 19(2):113–117
Levin KE, Clark AH, Duh QY, Demeure M, Siperstein AE, Clark OH (1992) Reoperative thyroid surgery. Surgery 111(6):604–609
Goretzki PE, Simon D, Frilling A, Witte J, Reiners C, Grussendorf M et al (1993) Surgical reintervention for differentiated thyroid cancer. Br J Surg 80(8):1009–1012
Tisell LE, Hansson G, Jansson S, Salander H (1986) Reoperation in the treatment of asymptomatic metastasizing medullary thyroid carcinoma. Surgery 99(1):60–66
Triponez F, Poder L, Zarnegar R, Goldstein R, Roayaie K, Feldstein V et al (2006) Hook needle-guided excision of recurrent differentiated thyroid cancer in previously operated neck compartments: a safe technique for small, nonpalpable recurrent disease. J Clin Endocrinol Metab 91(12):4943–4947
Rubello D, Salvatori M, Pelizzo MR, Rampin L, Fanti S, Gregianin M et al (2006) Radio-guided surgery of differentiated thyroid cancer using (131)I or 99mTc-Sestamibi. Nucl Med Commun 27(1):1–4
Ilgan S, Ozturk E, Yildiz R, Emer O, Ayan A, Gorgulu S et al (2010) Combination of preoperative ultrasonographic mapping and radioguided occult lesion localization in patients with locally recurrent/persistent papillary thyroid carcinoma: a practical method for central compartment reoperations. Clin Nucl Med 35(11):847–852
American Thyroid Association Surgery Working G, American Association of Endocrine S, American Academy of O-H, Neck S, American H, Neck S et al (2009) Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid 19(11):1153–1158
Stack BC Jr, Ferris RL, Goldenberg D, Haymart M, Shaha A, Sheth S et al (2012) American thyroid association consensus review and statement regarding the anatomy, terminology, and rationale for lateral neck dissection in differentiated thyroid cancer. Thyroid 22(5):501–508
Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE et al (2016) American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1):1–133
McCoy KL, Yim JH, Tublin ME, Burmeister LA, Ogilvie JB, Carty SE (2007) Same-day ultrasound guidance in reoperation for locally recurrent papillary thyroid cancer. Surgery 142(6):965–972
Grant CS (2015) Recurrence of papillary thyroid cancer after optimized surgery. Gland Surg 4(1):52–62
Tufano RP, Clayman G, Heller KS, Inabnet WB, Kebebew E, Shaha A et al (2015) Management of recurrent/persistent nodal disease in patients with differentiated thyroid cancer: a critical review of the risks and benefits of surgical intervention versus active surveillance. Thyroid 25(1):15–27
Hughes DT, Laird AM, Miller BS, Gauger PG, Doherty GM (2012) Reoperative lymph node dissection for recurrent papillary thyroid cancer and effect on serum thyroglobulin. Ann Surg Oncol 19(9):2951–2957
Harari A, Sippel RS, Goldstein R, Aziz S, Shen W, Gosnell J et al (2012) Successful localization of recurrent thyroid cancer in reoperative neck surgery using ultrasound-guided methylene blue dye injection. J Am Coll Surg 215(4):555–561
Rubello D, Salvatori M, Ardito G, Mariani G, Al-Nahhas A, Gross MD et al (2007) Iodine-131 radio-guided surgery in differentiated thyroid cancer: outcome on 31 patients and review of the literature. Biomed Pharmacother 61(8):477–481
Giles YS, Sarici IS, Tunca F, Sormaz IC, Salmaslioglu A, Adalet I et al (2014) The rate of operative success achieved with radioguided occult lesion localization and intraoperative ultrasonography in patients with recurrent papillary thyroid cancer. Surgery 156(5):1116–1126
Bellotti C, Castagnola G, Tierno SM, Centanini F, Sparagna A, Vetrone I et al (2013) Radioguided surgery with combined use of gamma probe and hand-held gamma camera for treatment of papillary thyroid cancer locoregional recurrences: a preliminary study. Eur Rev Med Pharmacol Sci 17(24):3362–3366
Lee L, Steward DL (2008) Sonographically-directed neck dissection for recurrent thyroid carcinoma. Laryngoscope 118(6):991–994
Gulcelik MA, Karaman N, Dogan L, Sahiner I, Akgul GG, Kahraman YS et al (2017) Radioguided occult lesion localization for locally recurrent thyroid carcinoma. Eur Arch Otorhinolaryngol 274(7):2915–2919
Rondeau G, Fish S, Hann LE, Fagin JA, Tuttle RM (2011) Ultrasonographically detected small thyroid bed nodules identified after total thyroidectomy for differentiated thyroid cancer seldom show clinically significant structural progression. Thyroid 21(8):845–853
Garbaccio V, Menga M, Mensa G, Passera R, Galati A, Codegone A et al (2017) Impact of radioguided occult lesion localization (ROLL) in the management of cervical recurrences from differentiated thyroid cancer. Q J Nucl Med Mol Imaging. https://doi.org/10.23736/S1824-4785.17.03027-8
Rowland KJ, Jin LX, Moley JF (2015) Biochemical cure after reoperations for medullary thyroid carcinoma: a meta-analysis. Ann Surg Oncol 22(1):96–102
Lee HS, Roh JL, Gong G, Cho KJ, Choi SH, Nam SY et al (2015) Risk factors for re-recurrence after first reoperative surgery for locoregional recurrent/persistent papillary thyroid carcinoma. World J Surg 39(8):1943–1950
Cayonu M, Acar A, Eryilmaz A, Oguz O (2014) Surgical approach and outcomes for revision surgery of the central neck compartment. J Craniofac Surg 25(5):1797–1800
Funding
This study received no funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of ınterest
Authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Institutional Ethical Committee at the University-Hospital Hacettepe approved this study (Approval number: GO 15/561-05).
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Tuncel, M., Süslü, N. Radioguided occult lesion localization in patients with recurrent thyroid cancer. Eur Arch Otorhinolaryngol 276, 1757–1766 (2019). https://doi.org/10.1007/s00405-019-05377-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-019-05377-w